GMAB
Genmab AS
NASDAQ: GMAB · HEALTHCARE · BIOTECHNOLOGY
$26.11
-2.54% today
Updated 2026-04-29
Market cap
$16.45B
P/E ratio
17.40
P/S ratio
4.42x
EPS (TTM)
$1.54
Dividend yield
—
52W range
$19 – $35
Volume
1.7M
Genmab AS (GMAB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $135.55M | $529.54M | $745.11M | $586.08M | $582.08M | $350.94M | $484.64M | $663.57M | $850.38M | $1.13B | $1.82B | $2.37B | $3.03B | $5.37B | $10.11B | $8.42B | $14.51B | $16.47B | $21.53B | $3.72B |
| Revenue growth (YoY) | — | +290.7% | +40.7% | -21.3% | -0.7% | -39.7% | +38.1% | +36.9% | +28.2% | +33.2% | +60.3% | +30.2% | +27.9% | +77.4% | +88.4% | -16.8% | +72.3% | +13.6% | +30.7% | -82.7% |
| Cost of revenue | — | — | $48.81M | — | $582.51M | $532.51M | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $0.00 | $0.00 | $226.00M | $985.00M | $309.24M |
| Gross profit | $135.55M | $529.54M | $696.30M | $586.08M | $-435000.00 | $-181.57M | $484.64M | $663.57M | $850.38M | $1.13B | $1.82B | $2.37B | $3.03B | $5.37B | $10.11B | $8.42B | $14.51B | $16.25B | $20.54B | $3.41B |
| Gross margin | 100.0% | 100.0% | 93.4% | 100.0% | -0.1% | -51.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.6% | 95.4% | 91.7% |
| R&D | $359.95M | $618.50M | $1.42B | $935.36M | — | — | $536.70M | $527.58M | $505.68M | $487.66M | $660.88M | $874.28M | $1.43B | $2.39B | $3.14B | $4.18B | $5.56B | $7.63B | $9.75B | $1.56B |
| SG&A | $37.11M | $38.59M | $143.53M | $148.75M | $160.25M | $67.85M | $64.61M | $66.74M | $79.53M | $91.22M | $102.41M | $146.99M | $213.69M | $342.00M | $661.00M | $1.28B | $2.68B | $3.30B | $3.79B | $626.00M |
| Operating income | $-472.21M | $-437.13M | $-722.03M | $-498.03M | $-160.69M | $-249.42M | $-116.68M | $69.25M | $265.18M | $730.38M | $1.05B | $1.34B | $1.38B | $2.64B | $6.31B | $2.95B | $6.27B | $5.32B | $6.70B | $1.25B |
| Operating margin | -348.4% | -82.6% | -96.9% | -85.0% | -27.6% | -71.1% | -24.1% | 10.4% | 31.2% | 64.5% | 58.0% | 56.8% | 45.6% | 49.2% | 62.4% | 35.1% | 43.2% | 32.3% | 31.1% | 33.6% |
| EBITDA | $-419.70M | $-317.72M | $-516.46M | $-77.11M | $-61.76M | $-192.75M | $-96.25M | $80.92M | $313.73M | $789.47M | $1.17B | $1.49B | $1.70B | $3.00B | $6.16B | $4.18B | $7.35B | $5.95B | $9.70B | $1.32B |
| EBITDA margin | -309.6% | -60.0% | -69.3% | -13.2% | -10.6% | -54.9% | -19.9% | 12.2% | 36.9% | 69.7% | 64.5% | 62.9% | 56.2% | 56.0% | 60.9% | 49.7% | 50.6% | 36.1% | 45.0% | 35.5% |
| EBIT | $-437.20M | $-331.98M | $-596.04M | $-160.89M | $-82.80M | $-207.79M | $-111.36M | $69.25M | $301.40M | $757.64M | $1.13B | $1.42B | $1.61B | $2.87B | $5.91B | $3.93B | $6.98B | $5.71B | $9.28B | $1.25B |
| Interest expense | $1.03M | $1.15M | $220.83M | $181.10M | $39.65M | $2.03M | $2.72M | $3.33M | $4.05M | $118000.00 | $213000.00 | $2.00M | $417000.00 | $7.00M | $10.00M | $13.00M | $21.00M | $27.00M | $120.00M | $61.05M |
| Income tax | $35.01M | $54.91M | $583000.00 | $5.91M | $20.87M | $5.92M | $-2.63M | $-4.75M | $-3.95M | $-5.99M | $-56.86M | $-39.83M | $139.83M | $693.00M | $1.15B | $961.00M | $1.49B | $1.28B | $1.32B | — |
| Effective tax rate | -8.7% | -16.7% | -0.1% | -0.6% | -6.9% | -1.0% | 0.5% | -4.4% | -1.3% | -0.8% | -5.0% | -3.7% | 8.7% | 24.2% | 19.4% | 24.5% | 21.5% | 22.8% | 14.4% | 0.0% |
| Net income | $-438.24M | $-383.37M | $-965.09M | $-1.01B | $-321.46M | $-596.37M | $-487.12M | $112.36M | $301.30M | $763.51M | $1.19B | $1.10B | $1.47B | $2.17B | $4.76B | $2.96B | $5.45B | $4.35B | $7.84B | $963.76M |
| Net income growth (YoY) | — | +12.5% | -151.7% | -4.7% | +68.2% | -85.5% | +18.3% | +123.1% | +168.1% | +153.4% | +55.5% | -7.0% | +33.4% | +47.1% | +119.7% | -37.9% | +84.4% | -20.2% | +80.2% | -87.7% |
| Profit margin | -323.3% | -72.4% | -129.5% | -172.5% | -55.2% | -169.9% | -100.5% | 16.9% | 35.4% | 67.4% | 65.4% | 46.7% | 48.7% | 40.4% | 47.1% | 35.1% | 37.6% | 26.4% | 36.4% | 25.9% |